Gene–gene effects on central processing of aversive stimuli

Emotional reactivity and regulation are fundamental to human behavior. As inter-individual behavioral variation is affected by a multitude of different genes, there is intense interest to investigate gene–gene effects. Functional sequence variation at two genes has been associated with response and resiliency to emotionally unpleasant stimuli. These genes are the catechol-O-methyltransferase gene (COMT Val158Met) and the regulatory region (5-HTTLPR) of the serotonin transporter gene. Recently, it has been proposed that 5-HTT expression is not only affected by the common S/L variant of 5-HTTLPR but also by an A to G substitution. Using functional magnetic resonance imaging, we assessed the effects of COMT Val158Met and both 5-HTT genotypes on brain activation by standardized affective visual stimuli (unpleasant, pleasant, and neutral) in 48 healthy subjects. Based on previous studies, the analysis of genotype effects was restricted to limbic brain areas. To determine allele-dose effects, the number of COMT Met158 alleles (i.e., lower activity of COMT) and the number of 5-HTT low expressing alleles (S and G) was correlated with the blood oxygen level-dependent (BOLD) response to pleasant or unpleasant stimuli compared to neutral stimuli. We observed an additive effect of COMT and both 5-HTT polymorphisms, accounting for 40% of the inter-individual variance in the averaged BOLD response of amygdala, hippocampal and limbic cortical regions elicited by unpleasant stimuli. Effects of 5-HTT and COMT genotypes did not affect brain processing of pleasant stimuli. These data indicate that functional brain imaging may be used to assess the interaction of multiple genes on the function of neuronal networks.

[1]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[2]  Thomas E. Nichols,et al.  Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate , 2002, NeuroImage.

[3]  H. Lachman,et al.  Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele , 1998, Molecular Psychiatry.

[4]  A. Grace,et al.  Modulation of Basolateral Amygdala Neuronal Firing and Afferent Drive by Dopamine Receptor Activation In Vivo , 1999, The Journal of Neuroscience.

[5]  Andreas Heinz,et al.  A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity , 2000, Biological Psychiatry.

[6]  David Goldman,et al.  Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. , 2006, American journal of human genetics.

[7]  J. Gray,et al.  Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety. , 2000, Journal of affective disorders.

[8]  R. Coppola,et al.  Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. , 2003, Archives of general psychiatry.

[9]  Joshua A. Bueller,et al.  COMT val158met Genotype Affects µ-Opioid Neurotransmitter Responses to a Pain Stressor , 2003, Science.

[10]  I. Ulmanen,et al.  Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.

[11]  Daniel R Weinberger,et al.  Imaging genomics. , 2003, British medical bulletin.

[12]  R. Weinshilboum,et al.  Genetics of red cell COMT activity: analysis of thermal stability and family data. , 1981, American journal of medical genetics.

[13]  R. Ebstein,et al.  Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT) , 2000, Molecular Psychiatry.

[14]  R. Hen,et al.  Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants , 2003, Science.

[15]  A. Meyer-Lindenberg,et al.  5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression , 2005, Nature Neuroscience.

[16]  M. Stein,et al.  Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder , 2006, Psychopharmacology.

[17]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[18]  Michael F Egan,et al.  A susceptibility gene for affective disorders and the response of the human amygdala. , 2005, Archives of general psychiatry.

[19]  M. Hamilton.  The Hamilton Rating Scale for Depression , 1986 .

[20]  L. Radloff.  The CES-D Scale , 1977 .

[21]  S. Rauch,et al.  Neurobiology of emotion perception I: the neural basis of normal emotion perception , 2003, Biological Psychiatry.

[22]  M. Bradley,et al.  Measuring emotion: the Self-Assessment Manikin and the Semantic Differential. , 1994, Journal of behavior therapy and experimental psychiatry.

[23]  Kenneth K Kidd,et al.  Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles , 1999, Biological Psychiatry.

[24]  R. Weinshilboum,et al.  Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. , 1999, Annual review of pharmacology and toxicology.

[25]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[26]  R. Ebstein,et al.  An Interaction between the Catechol O-Methyltransferase and Serotonin Transporter Promoter Region Polymorphisms Contributes to Tridimensional Personality Questionnaire Persistence Scores in Normal Subjects , 2000, Neuropsychobiology.

[27]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[28]  W. Maixner,et al.  Genetic basis for individual variations in pain perception and the development of a chronic pain condition. , 2005, Human molecular genetics.

[29]  P. Lang.  The emotion probe. Studies of motivation and attention. , 1995, The American psychologist.

[30]  A. Malhotra,et al.  A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. , 2002, The American journal of psychiatry.

[31]  C. Benkelfat,et al.  Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. , 2002, Archives of general psychiatry.

[32]  K. Luan Phan,et al.  Subjective rating of emotionally salient stimuli modulates neural activity , 2003, NeuroImage.

[33]  M. First,et al.  Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .

[34]  K. Ohara,et al.  Low activity allele of catechol‐o‐methyltransferase gene and Japanese unipolar depression , 1998, Neuroreport.

[35]  Stephen J. Guter,et al.  Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder , 2002, Molecular Psychiatry.

[36]  M. Fredrikson,et al.  Human fear conditioning is related to dopaminergic and serotonergic biological markers. , 2001, Behavioral neuroscience.

[37]  H. Tanabe,et al.  The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants , 2000, Molecular Psychiatry.

[38]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Steven P. Hamilton,et al.  Sequence Analysis of the Serotonin Transporter and Associations with Antidepressant Response , 2005, Biological Psychiatry.

[40]  Christian Büchel,et al.  Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter , 2005, Nature Neuroscience.

[41]  Francesco Fera,et al.  Dextroamphetamine Modulates the Response of the Human Amygdala , 2002, Neuropsychopharmacology.

[42]  D. Shields,et al.  Preliminary evidence of an association between bipolar disorder in females and the catechol‐O‐methyltransferase gene , 1998, Psychiatric genetics.

[43]  P. Delgado.  Depression: the case for a monoamine deficiency. , 2000, The Journal of clinical psychiatry.

[44]  Huda Akil,et al.  Neural circuits mediating stress , 1999, Biological Psychiatry.

[45]  B. Kolachana,et al.  Catechol-O-Methyltransferase Genotype and Dopamine Regulation in the Human Brain , 2003, The Journal of Neuroscience.

[46]  David Goldman,et al.  Genetics of alcoholism using intermediate phenotypes. , 2003, Alcoholism, clinical and experimental research.

[47]  R. Nussbaum,et al.  Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype , 2005, Nature Neuroscience.

[48]  Francesco Fera,et al.  Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease , 2002, The Journal of Neuroscience.

[49]  David Goldman,et al.  Interaction between serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates. , 2004, Archives of general psychiatry.

[50]  R Todd Constable,et al.  Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[51]  K. Mann,et al.  Candidate genes for alcohol dependence: animal studies. , 2003, Alcoholism, clinical and experimental research.

[52]  David Goldman,et al.  An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. , 2005, Alcoholism, clinical and experimental research.

[53]  D. Murphy,et al.  Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531 , 2006, Molecular Psychiatry.

[54]  Paul J. Laurienti,et al.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.

[55]  David Goldman,et al.  Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism , 2003, Psychiatric genetics.

[56]  J. Kennedy,et al.  Serotonin transporter polymorphisms and persistent, pervasive childhood aggression. , 2006, The American journal of psychiatry.

[57]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[58]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[59]  M. Egan,et al.  Serotonin Transporter Genetic Variation and the Response of the Human Amygdala , 2002, Science.

[60]  R. Weinshilboum,et al.  Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.

[61]  S. Southwick,et al.  Noradrenergic mechanisms in stress and anxiety: I. preclinical studies , 1996, Synapse.

[62]  David Goldman,et al.  The Genetics of Addictions: Uncovering the Genes , 2006 .

[63]  M. First,et al.  Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research version (SCID-I RV) , 2002 .

[64]  K. Lesch,et al.  Further evidence for a modulation of Novelty Seeking by DRD4 exon III, 5-HTTLPR, and COMT val/met variants , 2003, Molecular Psychiatry.

[65]  Andreas Heinz,et al.  Catechol-O-Methyltransferase val158met Genotype Affects Processing of Emotional Stimuli in the Amygdala and Prefrontal Cortex , 2005, The Journal of Neuroscience.

[66]  Henry Kranzler,et al.  Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects , 1997, Human Genetics.